ClinicalTrials.gg
RecruitingNCT06825650Updated Feb 13, 2025

Investigation of the Cultural Adaptation, Validity, and Reliability of the Turkish Version of the CAP Questionnaire

An observational study in Osteoarthritis, Back Pain and Fibromyalgia, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-13.

Sponsored by Hacettepe University · Observational

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 106 studies in Osteoarthritis with a site in Turkey — 22 open to participants now, 29 under way, none of them phase 3. Osteoarthritis · Turkey.

Planned enrollment
3rd of 42
300 · median 84
Started
2024
with 15 others
Observational
42 of 106
10 open now
Primary completion
2027-11
later than 27 of 28 live
Registered
73rd of 106
by date
Lead sponsor
9 of 106
Hacettepe University

Among the 106 studies in Osteoarthritis with a site in Turkey, this one is the 3rd largest by planned enrollment of the 42 observational ones that give a count, is one of 16 that started in 2024, is one of 42 observational ones, reaches primary completion later than 27 of the 28 other live ones, and was the 73rd registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

22 of the 106 studies in Osteoarthritis with a site in Turkey are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 106 studies in Osteoarthritis with a site in Turkey, or all of them as a file.
02

Study summary

The "CAP questionnaire," developed by modifying the CAP-Knee questionnaire to assess potential nociplastic pain features in painful musculoskeletal disorders, has been described. The "CAP questionnaire" is used in people with musculoskeletal pain and diagnostic subgroups of osteoarthritis, back pain, and fibromyalgia. There is no Turkish version of the CAP questionnaire. This study aims to investigate the cultural adaptation, validity, and reliability of the Turkish version of the "CAP questionnaire."

Read the detailed description

Chronic pain is a symptom shared by many musculoskeletal conditions, even when disease management is optimized. Musculoskeletal pathologies are reported to be an essential therapeutic target in pain management. However, these pathologies often do not adequately explain the pain or the reason for its persistence.

Central sensitization is the increased sensitivity of Central Nervous System (CNS) neurons to a standard nociceptive input. Pain that increases in intensity and distribution beyond that explained by musculoskeletal pathology has been termed "nociplastic pain." Measuring these CNS aspects of pain is a prerequisite for understanding their mechanistic basis and predicting future pain and responses to treatment. Chronic pain is associated with CNS dysfunction in several areas, including depression, anxiety, pain catastrophizing, cognitive dysfunction, sleep disturbance, and fatigue. Considering the increasing importance of assessing mood-related pain (nociplastic pain) The "CAP questionnaire," developed by modifying the CAP-Knee questionnaire to assess potential nociplastic pain features in painful musculoskeletal disorders, has been described.

03

Conditions studied

  • Osteoarthritis
  • Back Pain
  • Fibromyalgia

Keywords

  • nociplastic pain
  • central sensitization
  • back pain
  • osteoarthritis
  • fibromyalgia
  • pain
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population will consist of individuals who come to the university hospital for routine controls.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People with musculoskeletal pain and in diagnoses with OA, back pain, or FM
  • Above 18 years of age
  • of the participant

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of uncontrolled/other diseases (, congestive heart failure, endocrine system diseases, neurological, psychological diseases, etc.)
  • Pregnant women
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • Individuals with osteoarthritis

    Other: Questionnaire study

  • Individuals with back pain

    Other: Questionnaire study

  • Individuals with fibromyalgia

    Other: Questionnaire study

Interventions

  • OtherQuestionnaire study

    Questionnaire application

    Also known as: CAP questionnaire

06

What researchers measure

Primary outcomes

  1. Central Aspects of Pain Questionnaire (CAP)

    The CAP questionnaire consists of eight items assessing each of the eight characteristics linked to the central mechanisms of knee pain over the past week. These items assess neuropathic-like pain, fatigue, cognition, catastrophizing, anxiety, depression, sleep, and widespread pain.

    Time frame: Three months

Secondary outcomes

  1. BETY-Biopsychosocial Questionnaire

    Time frame: Three months

  2. Hospital Anxiety Depression Scale (HADS)

    Time frame: Three months

  3. Health Assessment Questionnaire (HAQ)

    Time frame: Three months

  4. Pain Catastrophizing Scale (PCS)

    Time frame: Three months

  5. Central Sensitisation Inventory (CSI)

    Time frame: Three months

  6. Short-Form of McGill's Pain Questionnaire

    Time frame: Three months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Will not be shared to protect the data of individuals

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Nov 2027, 36 months after the start.

Of 146 non-industry observational studies under Osteoarthritis, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 97. This study's planned 36 months is close to that.

Counting every sponsor, half of 228 studies reached it within 57 months; a quarter within 21 and three quarters within 141.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2025
First posted
Feb 13, 2025
StartActual
Nov 28, 2024
Primary completionEst.
Nov 28, 2027
CompletionEst.
Nov 28, 2027
Last update
Feb 13, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06825650
Responsible party
Orkun Tüfekçi (Principal Investigator, PT, PhD(c), Hacettepe University) — Principal investigator
First posted
Feb 13, 2025
Start date
Nov 28, 2024
Primary completion
Nov 28, 2027 (estimated)
Completion
Nov 28, 2027 (estimated)
Last update
Feb 13, 2025

Study contacts

Orkun Tüfekçi, PT, PhD (c)
Contact
orkuntf@gmail.com
5319502648

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion